Orbong, Kath Reign .
HRN: 19-61-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2022
10/17/2022
IVT
300mg
Q6
Pcap C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes